Redbiotec AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Redbiotec AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013447
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing products in the areas of CMV, HPV and influenza. Redbiotec also develops herpes vaccines. The company’s products find applications in the areas of cervical cancer induced by human papilloma virus; and influenza. It also offers customized solutions in biologics. The company operates through various pharmaceutical and biotech companies and universities. Redbiotec is headquartered in Schlieren, Switzerland.

Redbiotec AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Redbiotec AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 10
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 11
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 12
Redbiotec Extends Drug Discovery Agreement With Merck 13
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 14
Redbiotec Enters Into Drug Discovery Agreement With Merck 15
Redbiotec AG – Key Competitors 16
Redbiotec AG – Key Employees 17
Redbiotec AG – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Redbiotec AG, Pharmaceuticals & Healthcare, Key Facts 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Redbiotec AG, Deals By Therapy Area, 2011 to YTD 2017 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 10
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 11
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 12
Redbiotec Extends Drug Discovery Agreement With Merck 13
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 14
Redbiotec Enters Into Drug Discovery Agreement With Merck 15
Redbiotec AG, Key Competitors 16
Redbiotec AG, Key Employees 17

★海外企業調査レポート[Redbiotec AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Black Hills Corp (BKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Hills Corp (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, and wind …
  • OHB SE:企業の戦略・SWOT・財務情報
    OHB SE - Strategy, SWOT and Corporate Finance Report Summary OHB SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Fusion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of chemotherapy resistant cancers. Its pipeline product includes FPX-01, a radiolabeled antibody designed to internali …
  • CDW Corporation:企業の戦略・SWOT・財務情報
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Imperial d.d.:企業の戦略・SWOT・財務分析
    Imperial d.d. - Strategy, SWOT and Corporate Finance Report Summary Imperial d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Midatech Pharma US Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. It is a subsidiary of Midatech Pharma Plc. The company’s product portfolio includes …
  • Yasho Industries Ltd (541167):企業の財務・戦略的SWOT分析
    Yasho Industries Ltd (541167) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析
    Summary InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on …
  • U.S. Concrete Inc (USCR):企業の財務・戦略的SWOT分析
    Summary U.S. Concrete Inc (US Concrete) is a construction company that manufactures and markets ready-mixed concrete and aggregates. The company’s aggregate products include crushed stone, sand and gravel used in commercial, industrial and public works. It also provides specialty products such as ra …
  • Biglari Holdings Inc.:企業の戦略・SWOT・財務情報
    Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MorphoSys AG:企業のM&A・事業提携・投資動向
    MorphoSys AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MorphoSys AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Baoviet Holdings:企業の戦略・SWOT・財務分析
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bank of Ningbo Co. Ltd.:企業の戦略・SWOT・財務情報
    Bank of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Keysight Technologies Inc:企業の戦略・SWOT・財務情報
    Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Keysight Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vistra Energy Corp (VST):電力:M&Aディール及び事業提携情報
    Summary Vistra Energy Corp (Vistra Energy) is an investment holding company engaged in operation of integrated power business. The company through its subsidiaries is involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, and retail sales of e …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務分析
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • BioSyent Inc (RX):企業の財務・戦略的SWOT分析
    Summary BioSyent Inc (BioSyent), formerly Hedley Technologies Inc is a specialty pharmaceutical company that offers in-licensing or acquiring innovative pharmaceutical products and technologies to enhance human health. The company’s products include Aguettant System for pre-filled syringes, FeraMAX …
  • Partners Group Holding AG (PGHN):企業の財務・戦略的SWOT分析
    Summary Partners Group Holding AG (Partners Group) is a private market investment manager that offers private equity and investment services. The company manages investment programs and customized portfolios for institutional investors such as insurance companies, pension funds, and sovereign wealth …
  • AorTech International Plc (AOR):企業の財務・戦略的SWOT分析
    AorTech International Plc (AOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆